[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate

C28H29N4O3+ — CID 87438056

IUPAC[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate
SMILESO=C(C[N+]12CCC(CC1)C(OC(=O)C1c3ccccc3Cc3ccccc31)C2)Nc1cnccn1
InChIInChI=1S/C28H28N4O3/c33-26(31-25-16-29-11-12-30-25)18-32-13-9-19(10-14-32)24(17-32)35-28(34)27-22-7-3-1-5-20(22)15-21-6-2-4-8-23(21)27/h1-8,11-12,16,19,24,27H,9-10,13-15,17-18H2/p+1
InChIKeyDTJLBCUSIRTKLW-UHFFFAOYSA-O
MW469.57 g/mol
LogP3.30
Rot. Bonds5

About [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate

[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate (PubChem CID 87438056) has the molecular formula C28H29N4O3+ and a molecular weight of 469.57 g/mol. Its IUPAC name is [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate.

Molecular Properties

Compound Name[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate
PubChem CID87438056
Molecular FormulaC28H29N4O3+
Molecular Weight469.57 g/mol
Exact Mass469.22
IUPAC Name[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate
SMILESO=C(C[N+]12CCC(CC1)C(OC(=O)C1c3ccccc3Cc3ccccc31)C2)Nc1cnccn1
InChIInChI=1S/C28H28N4O3/c33-26(31-25-16-29-11-12-30-25)18-32-13-9-19(10-14-32)24(17-32)35-28(34)27-22-7-3-1-5-20(22)15-21-6-2-4-8-23(21)27/h1-8,11-12,16,19,24,27H,9-10,13-15,17-18H2/p+1
InChIKeyDTJLBCUSIRTKLW-UHFFFAOYSA-O
XLogP3.30
TPSA81.18 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500469.57
LogP ≤ 53.30
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate?
The IUPAC name of [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate (CID 87438056) is [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate.
What is the SMILES notation for [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate?
The canonical SMILES for [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate is O=C(C[N+]12CCC(CC1)C(OC(=O)C1c3ccccc3Cc3ccccc31)C2)Nc1cnccn1.
What is the InChIKey of [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate?
The InChIKey is DTJLBCUSIRTKLW-UHFFFAOYSA-O. The full InChI is InChI=1S/C28H28N4O3/c33-26(31-25-16-29-11-12-30-25)18-32-13-9-19(10-14-32)24(17-32)35-28(34)27-22-7-3-1-5-20(22)15-21-6-2-4-8-23(21)27/h1-8,11-12,16,19,24,27H,9-10,13-15,17-18H2/p+1.
What are the key properties of [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate?
[1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate has a molecular weight of 469.57 g/mol, XLogP of 3.30, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[2-oxo-2-(pyrazin-2-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 9,10-dihydroanthracene-9-carboxylate is sourced from PubChem (CID 87438056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).